US 8101791
Aminotetralin compounds as mu opioid receptor antagonists
granted A61KA61K47/12A61K47/14
Quick answer
US patent 8101791 (Aminotetralin compounds as mu opioid receptor antagonists) held by Theravance, Inc. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K47/12, A61K47/14, A61K47/26, A61K9/0019